【Deepening Industry-University-Research-Application and Promoting the Transformation of Achievements】Professor Liu Baolin of University of Shanghai for Science and Technology came to visit and exchange
Release time:
2023-07-16
The deep integration of industry, university and research is the core content and important realization form of innovation-driven development, and it is also the strategic focus of national scientific and technological innovation.
In order to actively respond to the national strategy, further accelerate the in-depth integration of industry, university and research, promote school-enterprise cooperation in a wider range, deeper and higher level, and achieve complementary advantages and collaborative innovation, Yinfeng Cryogenic Medical Research Center has cooperated with scientific research institutes in multidisciplinary fields at home and abroad for many years to actively promote the scientific research progress and achievements of cryogenic medicine.
On July 16, Professor Liu Baolin, Dean of the Institute of Science and Technology Development of University of Shanghai for Science and Technology and Vice Chairman of the Yinfeng Cryogenic Medicine Expert Committee, visited Yinfeng Cryogenic Medicine Research Center.

Prof. Baolin Liu
Dean of the Institute of Science and Technology Development of University of Shanghai for Science and Technology
Outstanding New Century Talent Program of the Ministry of Education
Group Leader of Cryobiology Group of Biobank Branch of China Pharmaceutical Biotechnology Association
Director of Shanghai Collaborative Innovation Center for Tumor Energy Therapy Technology and Devices
Director of Shanghai Biological Resources Cryogenic Preservation Professional Technical Service Platform
Vice Chairman of Yinfeng Cryogenic Medicine Expert Committee
During the visit, Professor Liu introduced the development history and current situation of cryomedicine with great interest, reviewed the specific progress of Yinfeng's life extension plan and its tissue and organ cryopreservation and resuscitation research project with the Yinfeng cryomedicine team, and affirmed the achievements of the Yinfeng cryomedicine team. At the same time, the two sides jointly imagined the future vision and bright future of cryomedicine.
Professor Liu Baolin and his team are committed to the study of cryopreservation methods of human cells and tissues, as well as the mechanism of cryogenic damage of cells and tissues, and the cryopreservation and freeze-drying of biological materials.

In 2019, Professor Liu Baolin and Yinfeng Cryogenic Medicine Research Team jointly carried out the research on "Tissue and Organ Preservation Research and System Construction of Life Resource Bank", as a biomedical resource in urgent need of Jinan City, the project was included in the "Quancheng Scholar" construction project, and Professor Liu Baolin won the honorary title of "Quancheng Scholar".
Over the years, Yinfeng Cryogenic Medicine and University of Shanghai for Science and Technology have carried out in-depth cooperation on the industry-university-research of cryogenic medicine, and the two sides have carried out scientific research cooperation and established a scientific research and production consortium based on the friendly principle of resource sharing. Conduct in-depth exchanges on the cryopreservation and recovery of tissues and organs, and conduct in-depth cooperation on the development of key cryopreservation technologies and equipment. At the same time, the two sides have made strong alliances in talent training, built a talent Xi base, jointly built an education fund, and promoted the exchange and introduction of talents, and achieved gratifying results.

Consolidate scientific research cooperation and promote the transformation of achievements. Based on the long-term good cooperation foundation and existing achievements of the two sides, in the future, the two sides will continue to devote themselves to the joint technical research of deep cryopreservation of complex tissues and organs, deepen the cooperation between industry, university and research institutes of cryogenic medicine, promote the practical implementation of more scientific research achievements, and create a new highland for the research and transformation of cryogenic medicine.

"Faculty of Medical Devices and Food" is now renamed "Faculty of Health Sciences and Engineering"
Here, we also look forward to more leading international and domestic laboratory research teams and research institutes to strengthen technical cooperation and translational research, and jointly contribute to the development of cryomedicine in China.
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.